Abstract
Cathepsin K is a cysteine proteinase expressed predominantly in osteoclasts. Cathepsin K cleaves key bone matrix proteins and is believed to play an important role in degrading the organic phase of bone during bone resorption. Pycnodysostosis, an autosomal recessive osteosclerosing skeletal disorder has recently been shown to result from mutations in the cathepsin K gene. Cathepsin K deficient mice generated by targeted disruption of this proteinase phenocopy many aspects of pycnodysostosis. They display an osteopetrotic phenotype with excessive trabeculation of the bone-marrow space accompanied by an altered ultrastructural appearance of the cathepsin K deficient osteoclasts. These cells also demonstrate an impaired resorptive activity in vitro. In contrast to other forms of osteopetrosis, which are due to disrupted osteoclastogenesis, cathepsin K deficiency is associated with an inhibition of osteoclast activity. Taken together the phenotype of cathepsin K knockout mice underlines the importance of this proteinase in bone remodelling.
Key words
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bossard, M.J., et al., 1996, Proteolytic activity of human osteoclast cathepsin K: Expression, purification, activation, and substrate identification. J. Biol. Chem. 271: 12517–12524.
Bræmme, D., and Okamoto K., 1995, The baculovirus cysteine proteinase has a cathepsin B-like S2-subsite specificity. Biol. Chem. Hoppe Seylor 376: 379–384.
Delaisse, J.M., et al., 1984, In vitro and in vivo evidence for the involvement of cysteine proteinases in bone resorption. Biochem. Biophys. Res. Commun. 125: 441–447.
Dodds, R.A., et al., 1998, Cathepsin K mRNAdetection is restricted to osteoclasts during fetal mouse development. J. Bone Miner. Res. 13: 673–682.
Drake, F.H., et al., 1996, Cathepsin K, but not cathepsin B, L, or S, is abundantly expressed in human osteoclasts. J. Biol. Chem. 271: 12511–12516.
Erlebacher, A., et al., 1995, Towards a molecular understanding of skeletal development. Cell 80: 371–378.
Edelson, J.G., et al., 1992, Pycnodysostosis. Orthopedic aspects with a description of 14 new cases. Clin. Orthoped. Rel. Res. 280: 264–276.
Everts, V., et al., 1985, Phagocytosis of bone collagen by osteoclasts in two cases of pycnodysostosis. Calcif. Tissue. Int. 37: 25–31.
Everts, V., et al., 1992, Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine proteinases and matrix metalloproteinases. J. Cell. Physiol. 150: 221–231.
Everts, V., et al., 1998, Cysteine proteinases and matrix metalloproteinases play distinct roles in the subosteoclastic resorption zone. J. Bone Miner. Res. 13: 1420–1430.
Everts, V., et al., 1999, J. Bone Miner. Res. 14: S356.
Everts, V., et al., 1999, Functional heterogeneity of osteoclasts: matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone. FASEB J.: 1219–1230.
Gelb, B.D., et al., 1996, Pycnodysostosis is a lysosomal disease caused by cathepsin K deficiency. Science 273: 1236–1238.
Ho, N., et al., 1999, Mutations of CTSK Result in Pycnodysostosis via a Reduction in Cathepsin K Protein. J. Bone Miner. Res. 14: 1649–1653.
Inaoka, T., et al., 1995, Molecular cloning of human cDNA for cathepsin K: Novel cysteine proteinase predominantly expressed in bone. Biochem. Biophys. Res. Commun. 206: 89–96.
Kafienah, W., et al., 1998, Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem. J. 331: 727–732.
Li, Y.P., et al., 1995, Cloning and complete coding sequence of a novel human cathepsin expressed in giant cells of osteoclastomas. J. Bone Miner. Res. 10: 1197–1202.
Mano, H., et al., 1996, Mammalian mature osteoclasts as estrogen target cells. Biochem. Biophys. Res. Commun. 223: 637–642.
Meredith, S.C., et al., 1978, Pycnodysostosis. A clinical, pathological, and ultramicroscopic study of a case. J. Bone Joint Surg. Am. 60: 1122–1127.
Pennypacker, B., et al., 1999, Bone density and strenght in cathepsin K null mice. J. Bone Miner. Res. 14: S549.
Ratankoko, J., et al., 1996, Mouse cathepsin K: cDNA cloning and predominant expression of the gene in osteoclasts and in some hypertrophic chondrocytes during mouse development. FEBS Lett. 393: 301–313.
Saftig, P., et al., 1998, Impaired osteoclastic bone resorption leads to osteopetrosis in Cathepsin K deficient mice. Proc. Natl. Acad. Sci. 95: 13453–13458.
Sedano, H.D., et al., 1968, Pycnodysostosis. Clinical and genetic considerations. Am. J. Dis. Child. 116: 70–77.
Shapiro, F., et al., 1980, Human osteopetrosis: A histological, ultrastructural, and biochemical study. J. Bone Joint Surg. 62A: 384–399.
Shi, G.P., et al., 1995, Molecular cloning of human cathepsin O, a novel endoproteinase and homologue of rabbit OC2. FEBS Lett. 357: 129–134.
Tezuka, K., 1994, Molecular cloning of a possiblecysteine proteinase predominantly expressed in osteoclasts. J. Biol. Chem. 269: 1106–1109.
Thompson, S.K., et al., 1997, Design of potent and selective human cathepsin K inhibitors that span the active site. Proc. Natl. Acad. Sci. USA 94: 14249–14254.
Velasco, G., et al., 1994, Human cathepsin O. Molecular cloning from a breast carcinoma, production of the active enzyme in Escherichia coli, and expression analysis in human tissues. J. Biol. Chem. 269: 27136–27142.
Wang, Z.Q., et al., 1992, Bone and haematopoetic defects in mice lacking c-fos. Nature 360: 741–745.
Yoshida, H., et al., 1990, The murine mutation osteopetrosis is in the coding region of the macrophage colony-stimulating factor gene. Nature 345: 442–444.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Saftig, P. et al. (2002). Functions of Cathepsin K in Bone Resorption. In: Langner, J., Ansorge, S. (eds) Cellular Peptidases in Immune Functions and Diseases 2. Advances in Experimental Medicine and Biology, vol 477. Springer, Boston, MA. https://doi.org/10.1007/0-306-46826-3_32
Download citation
DOI: https://doi.org/10.1007/0-306-46826-3_32
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46383-9
Online ISBN: 978-0-306-46826-1
eBook Packages: Springer Book Archive